Preserving and Enhancing Cognitive Longevity and Mental Health

Lucidify objectively detects delirium, or acute brain failure, by continuously and objectively monitoring the brain, with efficient algorithms (ML/AI) implemented in edge-based computing devices. Delirium is an early biomarker for brain injury, neuroinflammation, or organ failure. Early detection leads to treating the underlying cause and preserves brain health, prevents mental sequelae (depression, PTSD), and protects against death (3x rate), dementia (13x rate), disability, and loss-of-agency.  The early and objective diagnosis of delirium is such an unmet need that the FDA has signaled qualification of an object delirium device for Breakthrough Device Designation. Lucidify both preserves and empowers cognitive longevity and mental health.